All Stories

  1. Understanding transfusional iron distribution by investigating non-transferrin bound iron generation
  2. Inflammation and oxidant-stress in  -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial